Image 1
Disopyramide Phosphate Capsule
Product Images NDC 0093-3129
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Disopyramide Phosphate (NDC 0093-3129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
The text describes information about Teva's Isopyrami Capsules, an Rx-only medication containing disopyramide phosphate as its active ingredient, used for treating certain heart conditions. Each capsule contains 100mg of disopyramide base, and usual adult dosage is one capsule every six hours. It also includes information on storage and dispensing requirements. The medication is manufactured by Teva Pharmaceuticals and comes in a tight, light-resistant container. The text has a serialization coding area and an NDC number.*
Image 3
The text is a product description of Disopyramide Phosphate Capsules, USP used to treat cardiac arrhythmias. Each capsule contains 150mg of the medication and the usual adult dosage is one capsule every six hours. It is essential to keep this medication out of reach of children and store it in controlled room temperature. The manufacturer of the medication is Teva Pharmaceuticals located in Parsippany, NJ and the capsules come in a bottle containing 100 capsules. The expiration date is April 2022.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
